{
    "Trade/Device Name(s)": [
        "Prodigy Preferred Blood Glucose Monitoring System",
        "Prodigy\u00ae Preferred Blood Glucose Monitoring System",
        "Prodigy Preferred BGMS"
    ],
    "Submitter Information": "Prodigy Diabetes LLC",
    "510(k) Number": "K122338",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073118"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "November 5, 2013",
    "Summary Letter Received Date": "October 29, 2013",
    "Submission Date": "October 28, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Prodigy Preferred Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical method",
        "Amperometry",
        "Dry reagent biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Lancing Device",
        "Lancets",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Prodigy Preferred Blood Glucose Monitoring System, a meter and test strip system for quantitative glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from various sites; for self-testing by a single user with diabetes at home, as an aid to monitor diabetes control, not for diagnosis or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}